# JUPITER NEUROSCIENCES, INC. (JUNS) · Edgar & Edgarette company card

> Jupiter Neurosciences (JUNS) reported revenue of $0 million in FY2025, operating margin -40873% against a -3.8% median for pharmaceutical preparations, equity -32.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1679628 · fiscal year ended 2025-12-31 · 2 audited years read · [page](https://www.pops4.com/boards/company/JUNS) · [JSON](https://www.pops4.com/boards/company/JUNS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $21,796 |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | -40873.2% (prior year -Infinity%) |
| Net margin | -39662.8% |
| Operating cash flow | −$5M |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | $6M |
| Total equity | −$2M |
| Equity ÷ assets | -32.9% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -34.36 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late annual report notice in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$5.4M in FY2025); operating loss: a margin of -40873.2% in FY2025

## Edgarette's reading

Exposure: revenue $22K (FY2025). Experience: one year on record; operating margin -40873.2%, up from null. Soundness: equity -32.9% of assets (liabilities exceed assets). Credibility: 2 audited years, moderate weight. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -40873.2% against a -3.8% median.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-04-01 ([filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226014681/0001493152-26-014681-index.htm))
- Item 3.01 Exchange listing notice or transfer: 2, latest 2026-08-28 ([filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226040577/0001493152-26-040577-index.htm))
- Item 5.02 Director or officer change: 5, latest 2026-08-27 ([filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226040308/0001493152-26-040308-index.htm))

## Recent filings

- 8-K · filed 2026-09-03 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226041315/0001493152-26-041315-index.htm)
- 8-K · filed 2026-08-28 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226040577/0001493152-26-040577-index.htm)
- 8-K · filed 2026-08-27 · 1.01 Entry into a Material Definitive Agreement; 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226040308/0001493152-26-040308-index.htm)
- 8-K · filed 2026-08-24 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226039886/0001493152-26-039886-index.htm)
- 8-K · filed 2026-08-24 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226039785/0001493152-26-039785-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1679628/000149315226038463/0001493152-26-038463-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001679628.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1679628

## Cite

POPS4, Edgar & Edgarette: JUPITER NEUROSCIENCES, INC. (JUNS) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/JUNS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.